Patients with non-valvular atrial fibrillation now have an alternative to long-term warfarin medication therapy. Deborah® was among the first in the region to implant the newly FDA-approved WATCHMAN™ Left Atrial Appendage Closure (LAAC) Implant. This is a breakthrough for patients with AF who are suitable for warfarin therapy, but who have reason to seek a…
Learn MoreBy participating in this quiz, or screening or health assessment, I recognize and accept all risks associated with it. I understand that the program will only screen for certain risk factors and does not constitute a complete physical exam. For the diagnosis of a medical problem, I must see a physician for a complete medical exam. I release Deborah Heart and Lung Center and any other organization(s) involved in this screening, and their employees and agents, from all liabilities, medical claims or expenses which may arise from my participation. Thank you for investing in your health by participating today.